Resource Center


The Endocannabinoid System and the Gut

“The brain and the gut speak the same language” (1) Ethan Russo, MD, Renown Cannabinoid Scientist The endocannabinoid system (ECS) is a network of receptors and enzymes that are spread throughout the body. This system can interact with one’s own cannabinoids (endogenous or endocannabinoids) because of substances found in nature

How Do Cannabinoid Receptors Affect Motivation to Eat or Exercise?

Physical inactivity is a common factor in lifestyle diseases – and one that is often linked to the excessive consumption of fatty and/or sugary foods. The opposite scenario of excessive physical activity at the expense of caloric intake can also be harmful, as cases of anorexia nervosa illustrate. These scenarios


Omega-3 Fatty Acids Reduce Inflammation through Cannabinoids

The chemical compounds called cannabinoids, found in cannabis and hemp, are also produced naturally in the body from omega-3 fatty acids. A new study in animal tissue reveals the cascade of chemical reactions that convert omega-3 fatty acids into cannabinoids that have anti-inflammatory benefits. The findings are published in theRead

Legal Cannabis

Cannabidiol May Reduce Intestinal Inflammation

In this study, published in PLOS ONE, researchers explored the role of cannabidiol for intestinal inflammation. This research looked enteric glial cells (EGC), which plays a fundamental role in the maintenance of gut homeostasis. They assure the correct trophism of vicinal neurons in the myenteric plexus and actively participate in

Is the New York Times Picking on the Science for CBD?

A recent New York Times article, CBD is Everywhere, But Scientists Still Don’t Know Much About It, paints a picture of snake-oil sales, hyped-up claims and minuscule science. Is that true or a journalistic stretch? The article prompted Today’s Practitioner to dig up two well-researched studies from Cannabis and Cannabinoid

Understanding Cannabinoid Delivery Systems and Clinical Applications

There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The transformation of cannabinoids from herbal preparations into highly regulated prescription drugs is therefore progressingRead